Follow
sayantan mitra
sayantan mitra
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells
S Wang, WJ Placzek, JL Stebbins, S Mitra, R Noberini, M Koolpe, Z Zhang, ...
Journal of medicinal chemistry 55 (5), 2427-2436, 2012
942012
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
S Wang, R Noberini, JL Stebbins, SK Das, Z Zhang, B Wu, S Mitra, S Billet, ...
Clinical Cancer Research, clincanres. 2654.2012, 2012
692012
Structure− activity relationship analysis of peptides targeting the EphA2 receptor
S Mitra, S Duggineni, M Koolpe, X Zhu, Z Huang, EB Pasquale
Biochemistry 49 (31), 6687-6695, 2010
672010
Highly sensitive peptide-based probes for protein tyrosine phosphatase activity utilizing a fluorogenic mimic of phosphotyrosine
S Mitra, AM Barrios
Bioorganic & medicinal chemistry letters 15 (23), 5142-5145, 2005
572005
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45
SM Stanford, RG Panchal, LM Walker, DJ Wu, MD Falk, S Mitra, ...
Proceedings of the National Academy of Sciences 109 (35), 13972-13977, 2012
462012
Design and synthesis of potent bivalent peptide agonists targeting the EphA2 receptor
S Duggineni, S Mitra, I Lamberto, X Han, Y Xu, J An, EB Pasquale, ...
ACS medicinal chemistry letters 4 (3), 344-348, 2013
432013
PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity
R Noberini, S Mitra, O Salvucci, F Valencia, S Duggineni, N Prigozhina, ...
PloS one 6 (12), 2011
432011
Identifying selective protein tyrosine phosphatase substrates and inhibitors from a fluorogenic, combinatorial peptide library
S Mitra, AM Barrios
ChemBioChem 9 (8), 1216-1219, 2008
322008
Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4
S Duggineni, S Mitra, R Noberini, X Han, N Lin, Y Xu, W Tian, J An, ...
Biochemical pharmacology 85 (4), 507-513, 2013
282013
Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations
X Huan, J Shi, L Lim, S Mitra, W Zhu, H Qin, EB Pasquale, J Song
PloS one 8 (9), 2013
202013
A series of peptide-based, fluorogenic probes for protein tyrosine phosphatase activity.
S Mitra, AM Barrios
Analytical biochemistry 370 (2), 249, 2007
192007
Spin columns comprising poly (acid) membrane separation matrices, and methods of making and using the same
GG Jokhadze, S Mitra
US Patent 9,895,665, 2018
22018
Spin columns comprising poly (acid) membrane separation matrices, and methods of making and using the same
GG Jokhadze, S Mitra
US Patent 9,895,665, 2018
22018
Dry transfection compositions and methods for making and using the same
TP Quinn, S Mitra
US Patent App. 15/026,121, 2016
12016
Coumarin-based amino acids for use in enzyme activity and substrate specificity assays
AM Barrios, S Mitra
US Patent 9,045,507, 2015
12015
Coumarin-based amino acids for use in enzyme activity and substrate specificity assays
AM Barrios, S Mitra
US Patent 9,045,507, 2015
12015
Spin Columns Comprising Poly (Acid) Membrane Separation Matrices, and Methods Of Making and Using The Same
GG Jokhadze, S Mitra
US Patent App. 16/218,095, 2019
2019
Spin columns comprising poly (acid) membrane separation matrices, and methods of making and using the same
GG Jokhadze, S Mitra
US Patent 10,195,569, 2019
2019
Spin columns comprising poly (acid) membrane separation matrices, and methods of making and using the same
GG Jokhadze, S Mitra
US Patent 10,195,569, 2019
2019
Spin columns comprising poly (acid) membrane separation matrices, and methods of making and using the same
GG Jokhadze, S Mitra
US Patent 10,195,569, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20